Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four protein biomarkers to better distinguish cancer from noncancerous ...

Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...

As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Bottom Line: A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal ...

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

Catching pancreatic cancer early is among the most difficult challenges faced by medical providers, and that delay often ends in death. The NIH-supported researchers’ discovery of a new blood test, ...

Pancreatic cancer is often called a “silent killer” because it usually does not cause clear or specific symptoms in the early ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...